Showing results (471-480 of 901) with videos related to

Sort By:
Pageof 91
Nucleic Acids Research|March 29, 2000
MethyLight: a high-throughput assay to measure DNA methylationC A Eads, K D Danenberg, K Kawakami, et al.
Drug and Alcohol Review|February 18, 2004
The effect of the Safer Bars programme on physical aggression in bars: results of a randomized controlled trialKathryn Graham, D Wayne Osgood, Elaine Zibrowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopyManickam Muruganandham, Alan A Alfieri, Cornelia Matei, et al.
The Journal of Heredity|December 11, 2012
Genetic diversity of the Eurasian Otter (Lutra lutra) population in IsraelTali Magory Cohen, Tamar Narkiss, Amit Dolev, et al.
Proceedings of Machine Learning Research|May 31, 2024
Unsupervised Stain Decomposition via Inversion Regulation for Multiplex Immunohistochemistry ImagesShahira Abousamra, Danielle Fassler, Jiachen Yao, et al.
Proceedings. IEEE International Conference on Computer Vision|May 24, 2024
Multi-Class Cell Detection Using Spatial Context RepresentationShahira Abousamra, David Belinsky, John Van Arnam, et al.
Proceedings. IEEE Computer Society Conference on Computer Vision and Pattern Recognition|November 28, 2024
SI-MIL: Taming Deep MIL for Self-Interpretability in Gigapixel HistopathologySaarthak Kapse, Pushpak Pati, Srijan Das, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2011
Venous thromboembolic events with chemotherapy plus bevacizumab: a pooled analysis of patients in randomized phase II and III studiesHerbert I Hurwitz, Leonard B Saltz, Eric Van Cutsem, et al.
British Journal of Cancer|June 16, 2011
XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated resultsJ Cassidy, S Clarke, E Díaz-Rubio, et al.
Investigational New Drugs|October 29, 2008
Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancerWilliam P Tew, Delia Radovich, Eileen O'Reilly, et al.
Pageof 91